Croda International Plc (COIHY) Stock Analysis

Croda International Plc (COIHY) Materials & Commodity Exposure

Croda International Plc, a global specialty chemicals leader founded in 1925, develops and manufactures advanced solutions across diverse markets including personal care, life sciences, and industrial applications. Headquartered in Goole, UK, it leverages its four core divisions to deliver high-performance, often bio-based, chemical ingredients worldwide.

What Is the Investment Thesis for COIHY?

With a market capitalization of $6.03B and a P/E ratio of 69.68, the company commands a premium valuation reflecting its specialized product portfolio and strong market positions. Its gross margin of 35.8% indicates efficient production and pricing power within its niche segments, while a profit margin of 3.6% suggests room for operational leverage. Key growth catalysts include ongoing innovation in bio-based solutions, expansion in the Life Sciences sector through APIs and dietary supplements, and sustained demand for high-performance ingredients in Consumer Care. Croda's ability to develop tailored chemical solutions for complex applications across multiple continents positions it to capitalize on evolving industry trends and maintain its competitive edge, driving long-term value for shareholders.

Based on FMP financials and quantitative analysis

COIHY Key Highlights

Market Capitalization of $6.03B, reflecting its substantial presence in the global specialty chemicals market.

• Price-to-Earnings (P/E) ratio of 70.00, indicating investor confidence in its growth prospects and specialized business model.
• Gross Margin of 35.8%, demonstrating strong profitability from its advanced chemical solutions and efficient manufacturing processes.
• Profit Margin of 3.6%, showcasing the company's ability to convert revenue into net income amidst operational costs.
• Dividend Yield of 3.64%, providing a consistent return to shareholders, characteristic of established industrial companies.

Who Are COIHY's Competitors?

COIHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are COIHY's Key Strengths?

Global presence across Europe, Middle East, Africa, North America, Asia, and Latin America.

• Highly diversified product portfolio serving numerous end-markets.
• Strong focus on research and development of advanced, specialized chemical solutions.
• Leadership in bio-based and sustainable chemical technologies.
• Robust gross margin of 35.8% indicating strong product value and cost management.

What Are COIHY's Weaknesses?

Relatively low profit margin of 3.6% compared to its gross margin, suggesting high operating expenses or other cost pressures.

• High P/E ratio of 69.68, potentially indicating high growth expectations that must be met.
• Exposure to raw material price fluctuations inherent in the chemicals industry.
• Complexity of managing a global supply chain across diverse regulatory environments.

What Could Drive COIHY Stock Higher?

Continued innovation in bio-based and sustainable chemical solutions, driving adoption in environmentally conscious industries.

• Expansion of the Life Sciences division through new product introductions in active pharmaceutical ingredients and dietary supplements.
• Strategic partnerships and collaborations to enhance market penetration in emerging economies across Asia and Latin America.
• Development of advanced materials for high-growth sectors such as electric vehicle batteries and specialized electronics.
• Increased demand for high-performance ingredients in the global personal care market, leveraging Croda's specialized portfolio.

What Are the Key Risks for COIHY?

Rich valuation — a P/E of 69.68 runs well above the Basic Materials sector’s ~21.40x, leaving little room for a miss.

• Fluctuations in raw material costs, particularly for oleochemicals and other feedstock, impacting gross margins.
• Intense competition within the specialty chemicals industry from both global conglomerates and niche players.
• Adverse currency exchange rate movements, especially between GBP and USD, affecting ADR valuation and dividend payouts.
• Regulatory changes in environmental protection or chemical safety standards, requiring significant compliance investments.
• Economic downturns or reduced industrial activity impacting demand for performance technologies and industrial chemicals.

What Are the Growth Opportunities for COIHY?

• Growth opportunity 1: Expansion in Life Sciences through Active Pharmaceutical Ingredients (APIs) and dietary supplements. The global demand for specialized healthcare ingredients is consistently rising due to an aging population, increased health consciousness, and advancements in medical science. Croda's expertise in developing high-purity, functional APIs and nutritional components positions it to capture a larger share of this market, which is projected to grow significantly over the next decade. Its established relationships with pharmaceutical and nutraceutical companies provide a strong foundation for further penetration and product innovation in this high-margin sector.
• Growth opportunity 2: Increased adoption of sustainable and bio-based solutions, particularly in phase change materials (PCMs) and oleochemicals. As global environmental regulations tighten and consumer preferences shift towards eco-friendly products, Croda's portfolio of bio-based PCMs for energy storage, temperature control, and construction, alongside its oleochemicals derived from natural fats and oils, presents a substantial growth avenue. The market for sustainable chemicals is expanding rapidly, driven by industries seeking to reduce their carbon footprint and enhance product performance through renewable resources, offering long-term growth potential.
• Growth opportunity 3: Sustained demand for high-performance ingredients in the Consumer Care sector. The personal care market, encompassing skin, hair, sun, and color cosmetics, continuously seeks innovative ingredients that offer enhanced efficacy, sensory benefits, and natural origins. Croda's extensive range of specialized ingredients, from advanced emollients to active botanicals, allows it to cater to these evolving consumer and brand demands. The global personal care market, valued in the hundreds of billions, offers ongoing opportunities for Croda to introduce new formulations and expand its market share through technological differentiation and strong customer relationships.
• Growth opportunity 4: Advancements in Performance Technologies for industrial and automotive applications. The industrial and automotive sectors are undergoing significant transformations, driven by electrification, lightweighting, and the need for more durable and efficient materials. Croda's offerings, including lubricant additives, coatings, polymers, and specialized additives for battery and catalyst industries, are critical for these advancements. As electric vehicle adoption accelerates and industries seek to improve operational efficiency and material performance, Croda's tailored chemical solutions are poised for increased demand, particularly in high-growth areas like battery technology and advanced manufacturing.
• Growth opportunity 5: Innovation and market penetration in agricultural solutions. The global agricultural sector faces increasing pressure to enhance crop yields, improve animal health, and adopt sustainable farming practices. Croda's portfolio of crop protection additives, adjuvants, seed enhancement chemicals, animal health solutions, and chemical bio-stimulants directly addresses these challenges. With a growing global population and finite arable land, the demand for advanced agricultural inputs that boost productivity and resilience is robust. Croda's R&D in this area can lead to new product introductions and expanded market share in a critical and consistently growing industry.

What Threats Does COIHY Face?

• Intense competition from both large diversified chemical companies and specialized niche players.
• Economic downturns impacting demand in key end-markets like automotive or construction.
• Stringent environmental regulations and compliance costs.
• Disruptive technologies or alternative materials reducing demand for existing chemical solutions.
• Currency fluctuations impacting profitability for a global company with ADRs.

What Are COIHY's Competitive Advantages?

• Extensive R&D capabilities and intellectual property in specialty chemical formulations, creating high barriers to entry.
• Global manufacturing and distribution network, enabling efficient supply chain management and broad market reach.
• Diversified product portfolio and end-market exposure, reducing reliance on any single industry or customer segment.
• Strong customer relationships and technical expertise, allowing for co-development of bespoke solutions.
• Commitment to sustainability and leadership in bio-based chemistry, aligning with evolving market demands and regulatory trends.

What Does COIHY Do?

Croda International Plc, established in 1925 and headquartered in Goole, United Kingdom, has evolved into a global enterprise specializing in the development, manufacturing, and distribution of advanced chemical solutions. The company's extensive operational footprint spans across Europe, the Middle East, Africa, North America, Asia, and Latin America, demonstrating its wide-reaching market presence. Croda's business is strategically organized into four key divisions: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals, each catering to distinct and specialized market needs. Within the Consumer Care division, Croda is a crucial supplier of specialized ingredients for a broad spectrum of personal care applications, including skin, hair, sun, body, and baby care, as well as color cosmetics, self-tanning products, bath and shower formulations, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene products. The Life Sciences division focuses on critical sectors such as agriculture and healthcare, providing essential additives and adjuvants for crop protection, chemicals for seed enhancement and animal health, chemical bio-stimulants, and specialty additives for agricultural films. In healthcare, it contributes active pharmaceutical ingredients (APIs), dietary supplements, and skin health products. The Performance Technologies division serves industrial and automotive clients with lubricant additives, coatings, polymers, vehicle cleaning agents, and products for automotive textiles and fibers, alongside specialized additives for the plastics, battery, and catalyst industries. Its offerings also extend to construction chemicals, bitumen additives, materials and polymer additives for electronics and devices, emulsifiers, fuel and power generation additives, food additives, and specialty polymer additives for furniture and wood applications. Furthermore, the company supplies household, industrial, and institutional cleaning products, various lubricants, oleochemicals, chemicals for packaging, print, and paper, paints and coatings, thermal management products, plastic and rubber products, hygiene and industrial nonwovens, botanical extracts, tissues, textile auxiliaries, and water treatment chemicals. A significant area of innovation for Croda is its bio-based phase change materials (PCMs), designed for diverse applications such as buildings, clothing, electronics, food refrigeration, energy storage, and temperature-controlled packaging, underscoring its commitment to sustainable and high-performance solutions.

What Products and Services Does COIHY Offer?

• Develop, manufacture, and distribute advanced chemical solutions globally.
• Supply specialized ingredients for skin, hair, sun, body, and baby care, as well as color cosmetics and oral hygiene.
• Provide essential additives and adjuvants for crop protection, seed enhancement, and animal health in agriculture.
• Offer lubricant additives, coatings, polymers, and vehicle cleaning agents for industrial and automotive clients.
• Produce active pharmaceutical ingredients (APIs), dietary supplements, and skin health products for healthcare.
• Manufacture bio-based phase change materials (PCMs) for energy storage, temperature control, and various industrial applications.
• Supply chemicals for construction, electronics, food, household cleaning, packaging, paints, and water treatment.
• Operate through four key divisions: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals.

How Does COIHY Make Money?

• Research and development of innovative, high-performance specialty chemicals tailored to specific customer needs.
• Manufacturing and global distribution of a diverse portfolio of chemical ingredients and solutions.
• Serving a wide array of end-markets, including personal care, agriculture, healthcare, automotive, and industrial sectors.
• Focus on value-added, often bio-based, products that command premium pricing due to their specialized functionality.
• Revenue generation through direct sales to B2B customers and partnerships with industry leaders across continents.

What Industry Does COIHY Operate In?

Croda International Plc operates within the highly specialized and competitive Chemicals - Specialty industry, a segment of the broader Basic Materials sector. This industry is characterized by a focus on high-performance, value-added chemical products tailored for specific applications, rather than commodity chemicals. Key market trends include increasing demand for sustainable and bio-based solutions, growing innovation in life sciences for healthcare and agriculture, and the continuous need for advanced materials in consumer and industrial applications. Croda's position is strengthened by its global reach and diversified portfolio, which insulates it from volatility in any single end-market. The competitive landscape includes large diversified chemical companies and smaller niche players. Croda differentiates itself through its strong R&D capabilities, customer-centric approach to developing bespoke solutions, and a significant commitment to sustainability, particularly in bio-based phase change materials and oleochemicals. This strategic focus allows Croda to command premium pricing and maintain robust margins compared to commodity chemical producers.

Who Are COIHY's Key Customers?

• Global personal care and cosmetics brands requiring specialized ingredients for their product formulations.
• Agricultural companies and farmers seeking crop protection additives, seed enhancers, and animal health solutions.
• Pharmaceutical and nutraceutical manufacturers utilizing active pharmaceutical ingredients (APIs) and dietary supplements.
• Automotive and industrial manufacturers needing lubricant additives, coatings, and specialized materials.
• Construction, electronics, food, and household goods companies requiring specific chemical solutions for their products.

Company Profile

Croda International Plc operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Goole, GB. The company is led by CEO Stephen Edward Foots. COIHY has traded publicly since 2012.

Return on equity for Croda International Plc stands at 2.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.8%, showing how much profit it generates from its asset base. COIHY trades at a trailing price-to-earnings ratio of 69.68, above the Basic Materials sector average of ~21.40x. Its free cash flow yield is 4.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.99 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.4%, the inverse of the P/E and a quick read on earnings relative to price.

COIHY Valuation & Market Position

With a $6.03B market cap, Croda International Plc sits in the mid-cap segment of the market.

Quarterly Financial Performance: Croda International Plc

Revenue for Croda International Plc came in at $1.19B during Q2 FY2026, a 5.0% improvement versus the preceding quarter. The company recorded net income of $106.4M, with diluted EPS of $0.38. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Basic Materials. Across the four most recent quarters, COIHY averaged $0.27 in diluted EPS.

Croda International Plc's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.27 places it in the safe zone, indicating low near-term bankruptcy risk.

COIHY Financials

COIHY Latest News

COIHY Analyst Consensus

COIHY MoonshotScore

Common Questions About COIHY (Basic Materials)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources